Background: Colorectal cancer is the third most common cancer worldwide. In Egypt, it ranks the 7 th most common malignant tumor representing 3.47% of male cancers and 3% of female cancers. The relative frequency of colorectal cancer is about 9-12% with high male predominance 3:1. The prognostic value of conventional parameters for the evaluation of patient prognosis is limited. So, a need for novel prognostic markers is being largely considered.
Introduction
COLORECTAL Cancer (CRC) is a very common malignant tumor of the digestive tract, with about 1.2 million new cases and 600,000 deaths worldwide each year [1] . It is the third most common cancer all over the world [2] .
In Egypt, it ranks the 7 th most common malignant tumor representing 3.47% of male cancers and 3% of female cancers [3, 4] . The relative frequency of colorectal cancer is about 9-12% with high male predominance 3:1 [5] . The morbidity and mortality referable to heritable and sporadic carcinomas of the colon are substantial and affect young aged and elderly alike, with CRC being the third most common cause of cancer mortality in the developed world [6] . Indeed, the prognosis of colorectal carcinoma is related to several clinical and pathological parameters including tumor size, stage, and grade. Although these parameters do reflect the biological features of the tumor, they do not fully predict individual clinical outcome. Thus, a need for novel markers for optimum identification of patient's prognosis is being largely regarded. Studies have spotlighted on the possible contribution of new biological factors involved in the carcinogenic process as prognostic markers to help in guessing of clinical outcome of colorectal carcinoma cases [7] .
Karyopherin a s are a part of the importin/ karyopherin family and have a role in the procedure of protein carrying from the cytoplasm into the nucleus. Karyopherin a s bind the nuclear localization signals of proteins and moderate the transport of proteins measuring greater than 50kDa via nuclear pore complexes [8] .
Karyopherin a 2 (KPNA2) is an isoform of Karyopherin a s and has been demonstrated as a 2993 2994 KPNA2 Expression in Correlation to PCNA Expression in Cancer Colon marker of bad outcome in many tumors [9, 10] . However, only small-scale analyses of KPNA2 expression have been performed in CRC [11] .
The Proliferating Cell Nuclear Antigen (PCNA) is a non-histamine nuclear protein which arises in two functionally different forms. One of them, whose expression persists stable within the all cycle, is linked to DNA repair. The function of PCNA in this action lies in its interactions with DNA polymerase epsilon, whose fundamental role is DNA repair. The other form acts as an auxiliary protein for DNA polymerase delta, which is the principle replication enzyme [12, 13] .
As the PCNA expression occurs in proliferating cells, its level can be a marker of cell cycle kinetics and proliferative activity. PCNA level is thought to be related to adverse histopathologic tumor features (the degree of malignancy, vascular invasion, distant metastases) as well as patient survival [12, 13] . Therefore, PCNA has been described as a remarkable element in the outcome of many tumors including colorectal cancer [14] .
Material and Methods
The present work was carried out on 60 cases of colorectal carcinoma. Cases were retrospectively retrieved from the archives of Tanta Department of Pathology and private laboratories during the period of the research from May 2017 till June 2018 and patients' data were obtained from files of surgery and oncology reports. Approval from Research Ethics Committee (REC), Faculty of Medicine, Tanta University was taken antecedent to conducting study.
Cases were classified microscopically according to the 4th edition of the World Health Organization (WHO) classification system, 2010 [15, 16] . Cases were graded into well differentiated (Grade 1), moderately differentiated (Grade 2) and poorly differentiated (Grade 3) carcinomas according to the WHO criteria which was based on the extent of glandular differentiation as the following [17] ; Grade 1: Showing more than 95% of gland formation, Grade 2: Gland formation ranged between 50% and 95% and Grade 3: gland formation was lower than 50%.
Pathological staging of the studied colorectal carcinomas was determined according to the recommendations of the 8 th edition of AJCC, Cancer Staging Manual, 2017 by using the TNM staging system [18] .
Immunohistochemical staining was performed on 10% formalin fixed, paraffin embedded tissue blocks for evaluation of KPNA2 and PCNA expression. Sections were immunohistochemically labeled, using primary antibodies to KPNA2 (rabbit polyclonal antibody, Kit no. ab84440, Abcam, UK, dilution 1:150) and PCNA (mouse monoclonal antibody, clone number (PC 10), Kit no. AB29, Abcam, UK, dilution 1:10,000). KPNA2 expression was mainly nuclear in the tumor cells. An immunoreactivity scoring system was applied, according to reported procedures [19] . The percentage of positive cells was scored as follows: 0 (<5%, negative); 1 (5 25%, sporadic); 2 (25 50%, focal); and 3 (>50%, diffuse). The staining intensity was scored as follows: 0, no staining; 1, weak staining; 2, moderate staining; and 3, strong staining. The KPNA2 immunostaining score was calculated using the following formula: Immunostaining score= Positive cell score x staining intensity score. The immunostaining score ranged between 0 and 9. A score of >_4 indicated high KPNA2 expression.
PCNA expression was mainly nuclear. The reaction to PCNA was evaluated according to the following criteria; () lack of reaction to PCNA or reaction present in <60% of cells and (+) reaction present in >60% of cells [12, 13] .
Chi-square test was used as a test of significance to evaluate the association between categorized variables and p-value <0.05 was considered statistically significant. Statistical analyses were performed using SPSS software, Version 12.0.
Results
The clinicopathological characteristics of the studied cases were summarized in (Table 1) . We immunohistochemically evaluated 60 cases of colorectal carcinoma specimens for KPNA2 and PCNA expression and study the relation with different clinicopathological parameters (Tables 2,3 ). The correlation between KPNA2 score and PCNA percent in colorectal carcinoma studied cases was illustrated in (Table 4 ) and Graph (1).
Among 60 studied colorectal carcinoma cases, thirty-six cases (60%) were high KPNA2 expression and twenty-four cases (40%) were low KPNA2 expression. There was a statistically significant positive relation between KPNA2 expression and histopathological grade (p=0.005), depth of invasion (p=0.001), lymph node status ( p=0.001), perineural invasion (p=0.041) and vascular invasion (p=0.009). But didn't show statistically significant relation with histopathological type ( p=0.714). Maryam E. Abdo, et al. 2995 Out of 60 studied colorectal carcinoma cases, thirty-seven cases (61.7%) of cases were PCNA positive and twenty-three (23%) of cases were PCNA negative. The PCNA immunohistochemical expression showed statistically significant positive relation with histopathological grade ( p=0.002), depth of invasion (p=0.011), lymph node status (p=0.005). But didn't show statistically significant relation with histopathological type (p=0.603), vascular invasion (p=0.061) and perineural invasion (p=0.526).
There was a strong positive correlation between KPNA2 immunohistochemical score and PCNA immunohistochemical staining in the studied cases Correlation between KPNA2 score and PCNA% 0 1 2 3 4 5 6 7 8 9 10
KPNA2 score (r=0.937, p=0.001).
Graph (1): Correlation between KPNA2 score and PCNA%. 
Discussion
KPNA2 is an essential carrier that help in active transport of macromolecular cargo proteins between the cytoplasm and nucleus [20] . Many studies had noticed elevated levels of KPNA2 in a variety of malignancies after recognition of the prognostic significance of KPNA2 expression in breast carcinoma by Dahl et al., 2006 [21] . Aberrant KPNA2 levels has been described in a variety of other cancer forms. These include cervical cancer [22] esophageal cancer [23] , lung cancer [24] , ovarian cancer [25] , prostate cancer [26] , brain cancer [27] , liver cancer [28] and bladder cancer [29] . Most of these researches have explored the association between KPNA2 levels and case prognosis. Irrespective of cancer type, high levels of KPNA2 has been revealed to be associated with bad outcome [30] .
As regards to KPNA2 expression in the studied cases, there was statistically significant positive relation between KPNA2 immunohistochemical expression and the histopathological grade of the tumor. Similar results were detected by Zhang et al., (2015) [31] . This significant relation could be explained by the following; the increased KPNA2 expression detected in cancer tissues is mainly localized to the nucleus of cell. This may be due to cellular stress, including oxidative stress and heat shock, which may lead to the collection of KPNA2 in the nucleus of cells. It has been noticed that cells in high grade tumors typically exhibit a high level of oxidative stress [33, 34] . There was a statistically significant positive relation between KPNA2 immunohistochemical expression and depth of tumor invasion (T). Similar results were detected by Rachidi et al., (2013) in cancer colon [35] . There was statistically significant positive relation between KPNA2 immunohistochemical expression and lymph node status (N), vascular [31, 32] . There was no significant relation between KPNA2 immunohistochemical expression and histopathological type. The significant relation between the studied pathological parameters (depth of invasion, lymph node involvement, perivascular invasion and perineural invasion) and KPNA2 immunohistochemical expression can be explained by the following; Two cell cycle checkpoint mediators, Nijmegen Breakage Syndrome 1 (NBS1) and Checkpoint Kinase 2 (CHK2), have been demonstrated to be regulated by KPNA2 [36, 37] . Chk2 is translocated by KPNA2. Zannini et al., (2003) found that overexpression of KPNA2 correlates with an increase CHK2 nuclear import [38] that indicates aggressiveness and impacts negatively patient survival and outcome in many solid tumors including cancer colon [39] . Also, Mutations in CHK2 allow the cells to survive the repair mechanisms, which culminates in proliferation and survival of abnormal cells and results in increased genetic instability and tumor progression [40] . According to Sandrock et al., (2010) & Li et al., (2011), RAC-1 is also translocated by KPNA2 [41, 42] which play a role in cell cycle progression, cellular adhesion and migration [43] . RAC-1 role in promoting cancer colon progression was studied by Espina et al., (2008) [44] . Furthermore, KPNA2 is responsible for the import of NBS1, another DNA repair protein which also partake in carcinogenesis [45] .
Also, there was a systematic review and metaanalysis [46] that demonstrated the prognostic role of KPNA2 expression in some tumors collecting 24 studies of KPNA2 expression in different cancers and concluded that there is a significant association between KPNA2 immunohistochemical expression of solid tumors including cancer colon and primary outcome (overall survival) (Hazard Ratio; HR=1.767), secondary outcome (time to recurrence, recurrence free survival, progression free survival). The finding of this meta-analysis with the studied pathological parameters indicate that KPNA2 can be a helpful marker to detect colorectal carcinoma outcome.
Studies of PCNA expression in relation to the cell cycle revealed that PCNA levels are high during late G1 before onset of DNA synthesis, thereafter, reaching the highest point during Sphase with a decrease in G2 and M phases of the cell cycle and thus in this way the high elevation of PCNA levels correlated with cell proliferation and synthesis of DNA [47] . Expression of PCNA have been observed in a variety of malignancies; breast cancer [48] , Lymphoma [49] , Hepatocellular carcinoma [50] , Cervical carcinoma [51] . As regards to PCNA expression in these studied cases, there was significant positive relation between PCNA expression and histopathological grade, depth of invasion & lymph node status (N). There was no significant relation between PCNA immunohistochemical expression and histopathological types, vascular invasion and perineural invasion. The same result was detected by Guzinska-Ustymowicz et al., (2008) [13, 52] .
There was strong positive correlation between KPNA2 and PCNA immunohistochemical expression. This result can explain the role of KPNA2 in cellular proliferation. The proliferative role of KPNA2 also had been studied by Zhang et al., (2015) [31] when they correlate the relation between KPNA2 immuno-histochemical expression and the presence of Ki-67 which is a proliferative marker too and found a positive correlation between them. This also was supported by the results in other solid cancers like Gluz et al., (2008) in breast cancer [9] ; Sakai et al., (2010) in oesphageal cancer [10] and Gousias et al., (2012) in astrocytoma [53] . All these studies including the current one suggests that KPNA2 may have a potential role in colon cancer cell proliferation as PCNA and useful predictive marker for poor prognosis.
